NCT07328932

Brief Summary

Urinary tract stones are a common condition affecting the kidney, ureter, bladder, and urethra. Uric acid stones represent an important subtype of urinary stones and require different prevention and treatment strategies compared with other stone types. However, accurate identification of uric acid stones before treatment remains challenging in routine clinical practice. This multicenter observational study aims to develop and validate a precision classification model to distinguish uric acid urinary tract stones from non-uric acid stones using multimodal parameters. These parameters include patients' clinical characteristics, laboratory test results, and computed tomography (CT) imaging features. Patients undergoing surgical treatment for urinary tract stones at participating centers will be enrolled. Stone composition determined by infrared spectroscopy after surgery will be used as the reference standard. By integrating clinical, laboratory, and imaging data, this study seeks to establish a practical and reliable model to improve the classification of uric acid stones and support individualized clinical management.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,650

participants targeted

Target at P75+ for all trials

Timeline
14mo left

Started Oct 2025

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress39%
Oct 2025Oct 2027

Study Start

First participant enrolled

October 20, 2025

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

December 12, 2025

Completed
28 days until next milestone

First Posted

Study publicly available on registry

January 9, 2026

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 20, 2027

Expected
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 20, 2027

Last Updated

January 9, 2026

Status Verified

January 1, 2026

Enrollment Period

1.8 years

First QC Date

December 12, 2025

Last Update Submit

January 8, 2026

Conditions

Keywords

Uric acid stonesUrinary tract stonesComputed tomographyMultimodal parametersPrediction model

Outcome Measures

Primary Outcomes (1)

  • Accuracy of multimodal model for identifying uric acid urinary stones.

    The primary outcome is the diagnostic performance of a multimodal classification model for identifying uric acid urinary tract stones. The model integrates clinical characteristics, laboratory parameters, and computed tomography imaging features. Stone composition determined by postoperative infrared spectroscopy is used as the reference standard. Model performance will be evaluated using discrimination metrics such as the area under the receiver operating characteristic curve.

    Perioperatively

Study Arms (2)

Uric Acid Urinary Stones

Patients with urinary tract stones classified as uric acid stones based on postoperative infrared spectroscopy analysis.

Other: No intervention (observational study)

Non-Uric Acid Urinary Stones

Patients with urinary tract stones classified as non-uric acid stones based on postoperative infrared spectroscopy analysis.

Other: No intervention (observational study)

Interventions

This is an observational cross-sectional study. Participants are not assigned to any intervention as part of the study. All clinical management, imaging examinations, and laboratory tests are performed as part of routine clinical care.

Non-Uric Acid Urinary StonesUric Acid Urinary Stones

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The study population consists of adult patients with urinary tract stones who undergo surgical treatment at participating centers. Eligible participants include patients with kidney, ureteral, bladder, or urethral stones, with available clinical information, laboratory test results, computed tomography imaging, and postoperative stone composition analysis.

You may qualify if:

  • Patients with a confirmed diagnosis of urinary tract stones, including kidney stones, ureteral stones, bladder stones, or urethral stones.
  • Patients who undergo surgical treatment for urinary tract stones at participating centers during the study period, including ureteroscopy or flexible ureteroscopy lithotripsy, percutaneous nephrolithotomy, pyelolithotomy or ureterolithotomy, or transurethral cystolithotripsy.
  • Patients whose stone composition is determined by postoperative infrared spectroscopy analysis.

You may not qualify if:

  • Patients with multiple stones or stones located at multiple sites, such as multiple renal stones or concomitant kidney and ureteral stones, to avoid discrepancies between computed tomography measurements of the target stone and stone composition analysis.
  • Pregnant or breastfeeding women.
  • Patients younger than 18 years of age.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine

Shanghai, Shanghai Municipality, 200000, China

Location

Related Publications (5)

  • Bultitude M, Smith D, Thomas K. Contemporary Management of Stone Disease: The New EAU Urolithiasis Guidelines for 2015. Eur Urol. 2016 Mar;69(3):483-4. doi: 10.1016/j.eururo.2015.08.010. Epub 2015 Aug 21. No abstract available.

  • Mandel NS, Mandel IC, Kolbach-Mandel AM. Accurate stone analysis: the impact on disease diagnosis and treatment. Urolithiasis. 2017 Feb;45(1):3-9. doi: 10.1007/s00240-016-0943-0. Epub 2016 Dec 3.

  • Zeng G, Mai Z, Xia S, Wang Z, Zhang K, Wang L, Long Y, Ma J, Li Y, Wan SP, Wu W, Liu Y, Cui Z, Zhao Z, Qin J, Zeng T, Liu Y, Duan X, Mai X, Yang Z, Kong Z, Zhang T, Cai C, Shao Y, Yue Z, Li S, Ding J, Tang S, Ye Z. Prevalence of kidney stones in China: an ultrasonography based cross-sectional study. BJU Int. 2017 Jul;120(1):109-116. doi: 10.1111/bju.13828. Epub 2017 Mar 21.

  • Chew BH, Wong VKF, Halawani A, Lee S, Baek S, Kang H, Koo KC. Development and external validation of a machine learning-based model to classify uric acid stones in patients with kidney stones of Hounsfield units < 800. Urolithiasis. 2023 Sep 30;51(1):117. doi: 10.1007/s00240-023-01490-y.

  • Wang Z, Yang G, Wang X, Cao Y, Jiao W, Niu H. A combined model based on CT radiomics and clinical variables to predict uric acid calculi which have a good accuracy. Urolithiasis. 2023 Feb 6;51(1):37. doi: 10.1007/s00240-023-01405-x.

MeSH Terms

Conditions

Urinary Calculi

Interventions

Observation

Condition Hierarchy (Ancestors)

UrolithiasisUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesCalculiPathological Conditions, AnatomicalPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

MethodsInvestigative Techniques

Study Officials

  • Jian Zhuo, PhD

    Department of Urology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
CROSS SECTIONAL
Target Duration
1 Day
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

December 12, 2025

First Posted

January 9, 2026

Study Start

October 20, 2025

Primary Completion (Estimated)

August 20, 2027

Study Completion (Estimated)

October 20, 2027

Last Updated

January 9, 2026

Record last verified: 2026-01

Data Sharing

IPD Sharing
Will not share

Individual participant data will not be shared because the study involves multicenter clinical data containing sensitive personal and imaging information. Data sharing is restricted by institutional policies, ethical approvals, and data protection regulations.

Locations